Multi-Omics Integration in Mice With Parkinson’s Disease and the Intervention Effect of Cyanidin-3-O-Glucoside

Abstract

BackgroundParkinson’s disease (PD) is a multifactorial degenerative disease of the central nervous system, which affects mostly older adults. To date, research has focused on the progression of PD. Simultaneously, it was confirmed that the imbalances in gut microbiota are associated with the onset and progression of PD. Accurate diagnosis and precise treatment of PD are currently deficient due to the absence of effective biomarkers.MethodsIn this study, the pharmacodynamic study of cyanidin-3-O-glucoside in PD mice was used. It intends to use the “imbalance” and “balance” of intestinal microecology as the starting point to investigate the “gut-to-brain” hypothesis using metabolomic-combined 16S rRNA gene sequencing methods. Simultaneously, metabolomic analysis was implemented to acquire differential metabolites, and microbiome analysis was performed to analyze the composition and filter the remarkably altered gut microbiota at the phylum/genera level. Afterward, metabolic pathway and functional prediction analysis of the screened differential metabolites and gut microbiota were applied using the MetaboAnalyst database. In addition, Pearson’s correlation analysis was used for the differential metabolites and gut microbiota. We found that cyanidin-3-O-glucoside could protect 1-methyl-4-phenyl-1,2,3,6− tetrahydropy ridine (MPTP)-induced PD mice.ResultsMetabolomic analysis showed that MPTP-induced dysbiosis of the gut microbiota significantly altered sixty-seven metabolites. The present studies have also shown that MPTP-induced PD is related to lipid metabolism, amino acid metabolism, and so on. The 16S rRNA sequencing analysis indicated that 5 phyla and 22 genera were significantly altered. Furthermore, the differential gut microbiota was interrelated with amino acid metabolism, and so on. The metabolites and gut microbiota network diagram revealed significant correlations between 11 genera and 8 differential metabolites.ConclusionIn combination, this study offers potential molecular biomarkers that should be validated for future translation into clinical applications for more accurately diagnosing PD. Simultaneously, the results of this study lay a basis for further study of the association between host metabolisms, gut microbiota, and PD.

Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling Pathway

“…Kaewmool et al obtained similar results studying the effects of Cyanidin 3-O-glucoside, anthocyanins responsible for the red and blue pigments of different fruits and well known for its neuroprotective effects [138]. Authors demonstrated that cyanidin treatment (2.5-5-10 µM) for 4 h inhibits the NF-κB and p38 pathways, thus affecting the expression of pro-inflammatory cytokines in microglial BV2 cells [138,139].…”

The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease

“…Cyanidin 3-O-glucoside belongs to the anthocyanins class; it is present in plants such as berries and soybean fruits, where it is responsible for the red, purple, and blue pigments. Cyanidin has been reported to act as neuroprotector in several disorders, such as AD, Parkinson’s disease, and multiple sclerosis [ 211 , 212 , 213 , 214 , 215 ]. The anti-AD effect is evidenced in the inhibition of Aβ amyloid accumulation.…”

MOGAT: A Multi-Omics Integration Framework Using Graph Attention Networks for Cancer Subtype Prediction

“…Integrating multi-omics data is crucial for gaining a comprehensive understanding of complex diseases like Alzheimer’s [ 1 ], Parkinson’s [ 2 , 3 ], and cancer [ 4 ]. However, it is a difficult task that requires advanced computational methods.…”